M. F. Stewart

发表

Scott Podgorny, M. Quick, H. J. Christian, 2016 .

Are patients with familial hypercholesterolaemia well managed in lipid clinics? An audit of eleven clinics from the Department of Health Familial Hypercholesterolaemia Cascade Testing project

M. F. Stewart, S. Humphries, S. Yazdgerdi, 2008, Annals of clinical biochemistry.

Biochemical diagnosis of phaeochromocytoma: two instructive case reports.

M. F. Stewart, C. Weinkove, P. Reed, 1993, Journal of clinical pathology.

Best practice in primary care pathology: review 10

M. F. Stewart, A. Mcculloch, A. Kelly, 2007, Journal of Clinical Pathology.

Family tracing to identify patients with Familial Hypercholesterolaemia: the second Audit of the Department of Health Familial Hypercholesterolaemia Cascade Testing Project

S. G. Hadfield, M. F. Stewart, S. Humphries, 2009, Annals of clinical biochemistry.

Thyroid Function Tests in Patients with Familial Dysalbuminaemic Hyperthyroxinaemia (FDH)

M. F. Stewart, W. Ratcliffe, I. Roberts, 1986, Annals of clinical biochemistry.

Heparin Selectively Affects the Quantification of MicroRNAs in Human Blood Samples

M. F. Stewart, M. Badminton, J. Rhodes, 2013 .

Bromocriptine inhibits pro-opiomelanocortin mRNA and ACTH precursor secretion in small cell lung cancer cell lines.

M. F. Stewart, W. Farrell, A. Clark, 1992, The Journal of clinical investigation.

Constitutive synthesis of 1,25-dihydroxyvitamin D3 by a human small cell lung cancer cell line.

M. F. Stewart, E. Mawer, A. White, 1994, The Journal of clinical endocrinology and metabolism.

The synthesis of ACTH and related peptides by tumours.

M. F. Stewart, A. Clark, A. White, 1990, Bailliere's clinical endocrinology and metabolism.

Small cell lung cancer cell lines secrete predominantly ACTH precursor peptides not ACTH.

M. F. Stewart, A. White, P. Twentyman, 1989, British Journal of Cancer.

Hypophosphataemia in General Practice Patients

M. F. Stewart, A. Olukoga, J. M. Guy, 1999, Annals of clinical biochemistry.

Direct measurement of the precursors of adrenocorticotropin in human plasma by two-site immunoradiometric assay.

J G Ratcliffe, M. F. Stewart, J. Ratcliffe, 1988, The Journal of clinical endocrinology and metabolism.

Acute Hepatic Porphyrias: "Purple Flags"-Clinical Features that should Prompt Specific Diagnostic Testing.

M. F. Stewart, H. Bonkovsky, R. Desnick, 2021, The American journal of the medical sciences.

Audit of the Use of Regular Haem Arginate Infusions in Patients with Acute Porphyria to Prevent Recurrent Symptoms.

M. F. Stewart, P. Stein, J. Marsden, 2015, JIMD reports.

Best practice guidelines on clinical management of acute attacks of porphyria and their complications

M. F. Stewart, P. Stein, M. Badminton, 2013, Annals of clinical biochemistry.

Best practice guidelines on first-line laboratory testing for porphyria

M. F. Stewart, J. Marsden, M. Badminton, 2017, Annals of clinical biochemistry.

An unusual bullous eruption: olanzapine induced pseudoporphyria

M. F. Stewart, P. Weston, A. Bakshi, 2019, BMJ Case Reports.

Comparison of ACTH and ACTH precursor peptides secreted by human pituitary and lung tumour cells in vitro.

M. F. Stewart, W. Farrell, A. White, 1990, The Journal of endocrinology.

Review of hepatocellular cancer, hypertension and renal impairment as late complications of acute porphyria and recommendations for patient follow-up

M. F. Stewart, 2012, Journal of Clinical Pathology.

Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritance.

M. F. Stewart, M. Badminton, G. Elder, 2009, The Journal of investigative dermatology.

Pro-opiomelanocortin gene expression and peptide secretion in human small-cell lung cancer cell lines.

M. F. Stewart, W. Farrell, A. Clark, 1989, Journal of molecular endocrinology.

Defective glucocorticoid regulation of proopiomelanocortin gene expression and peptide secretion in a small cell lung cancer cell line.

M. F. Stewart, W. Farrell, A. Clark, 1990, The Journal of clinical endocrinology and metabolism.

Acute intermittent porphyria and phaeochromocytoma: shared features

M. F. Stewart, J. New, P. Reed, 2006, Journal of Clinical Pathology.

Fatal Isoniazid Poisoning

M. F. Stewart, T. Richardson, A. J. Freemont, 1995, Annals of clinical biochemistry.

Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.

M. F. Stewart, A M Jennings, A. White, 1994, The Journal of clinical endocrinology and metabolism.

Acute intermittent porphyria: fatal complications of treatment.

M. F. Stewart, P. Stein, R. Sarkany, 2012, Clinical medicine.

Pseudoexon activation in the HMBS gene as a cause of the nonerythroid form of acute intermittent porphyria.

M. F. Stewart, M. Badminton, J. Rhodes, 2013, Clinical chemistry.

Review of hepatocellular cancer, hypertension and renal impairment as late complications of acute porphyria and recommendations for patient follow-up

M. F. Stewart, 2012, Journal of Clinical Pathology.